Hillary Clinton is calling for greater regulatory scrutiny of major health insurance mergers, saying “I am very skeptical of the…
Late last week, the Centers for Medicare and Medicaid Services (CMS) finalized its proposal to pay for biosimilars under Medicare…
For many people dealing with hepatitis C, insurance providers are determining whether or not they should receive treatment. Unfortunately, in…
Report Highlights Need for Policy Solutions to Improve Industry Shortcomings Washington, D.C. – The Obama administration said many consumers will…
As open enrollment begins, it is important to avoid so-called “skinny health care plans,” which are plans that offer lower…
According to a recent Kaiser Family Foundation poll, the country is split down the middle over their impression of the…
A new report from the Department of Health and Human Services (HHS) finds that silver health plan premiums are increasing…
A new study by the American Association for the Study of Liver Diseases examined 2,350 patients prescribed hepatitis C cures…
Price gouging in the specialty drug market is driving the cost of vital drugs up to $750 to $1,000 a…
Despite responding to national outrage by promising to lower the price of Daraprim, a drug that fights parasitic infections, pharmaceutical…